Treace Medical Concepts TMCI
NASDAQ TMCI
$4.33 -0.23 (-5.04%)
At close: Aug 20, 2026 · 2:23 PM UTC

Treace Medical Concepts (TMCI) Invested Capital (2020 - 2026)

Treace Medical Concepts' (TMCI) quarterly Invested Capital came in at $1.8 million in Q1 2026, up 3846.67% YoY from $45000.0 in Q1 2025, and up 1.78% on a QoQ basis from $1.7 million in Q4 2025.

Treace Medical Concepts (TMCI) Invested Capital (2020 - 2026) Analysis & Trends

Treace Medical Concepts (TMCI) has 3 years of Invested Capital data on file, last reported at $1.8 million in Q1 2026.

  • Quarterly Invested Capital rose 3846.67% year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.4 million (up 14193.33% YoY) and the FY2025 annual result came in at $1.7 million, changed N/A from the prior year.
  • Invested Capital climbed to $1.8 million in Q1 2026, from $1.7 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $1.8 million in Q3 2025 to a low of $45000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Abbott Laboratories 199.44 Bn 193.84 Bn 7.27 Bn 3.01 Bn
2 Stryker 127.32 Bn 123.85 Bn 4.50 Bn 750.00 Mn
3 Medtronic 118.87 Bn 109.65 Bn 6.41 Bn 1.79 Bn
4 Boston Scientific 73.47 Bn 72.93 Bn 3.85 Bn 1.71 Bn
5 Edwards Lifesciences 51.90 Bn 47.65 Bn 1.35 Bn -
6 Dexcom 34.30 Bn 32.36 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.74 Bn 31.63 Bn 2.18 Bn 2.00 Mn
8 Koninklijke Philips 26.35 Bn 23.03 Bn 4.55 Bn 1.34 Bn
9 Steris 23.05 Bn 22.56 Bn 684.20 Mn 243.40 Mn
10 Treace Medical Concepts 281.67 Mn 236.05 Mn 35.61 Mn 3.17 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 3.17 Mn
Mar 31, 2026 1.78 Mn
Dec 31, 2025 1.75 Mn
Sep 30, 2025 1.80 Mn
Jun 30, 2025 1.11 Mn
Mar 31, 2025 45,000.00
Dec 31, 2020 1.79 Mn